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PEG/Dextran Double Layer 
Influences Fe Ion Release and 
Colloidal Stability of Iron Oxide 
Nanoparticles
M. Rezaa Mohammadi  1, Andrey V. Malkovskiy1, Preetha Jothimuthu1, Kwang-Min Kim1, 
Mansi Parekh1, Mohammed Inayathullah1, Yan Zhuge2 & Jayakumar Rajadas1,3
Despite preliminary confidence on biosafety of polymer coated iron oxide nanoparticles (SPIONs), 
toxicity concerns have hampered their clinical translation. SPIONs toxicity is known to be due to 
catalytic activity of their surface and release of toxic Fe ions originating from the core biodegradation, 
leading to the generation of reactive oxygen species (ROS). Here, we hypothesized that a double-layer 
polymeric corona comprising of dextran as an interior, and polyethylene glycol (PEG) as an exterior 
layer better shields the core SPIONs. We found that ROS generation was cell specific and depended 
on SPIONs concentration, although it was reduced by sufficient PEG immobilization or 100 µM 
deferoxamine. 24 h following injection, PEGylated samples showed reduction of biodistribution in liver, 
heterogenous biodistribution profile in spleen, and no influence on NPs blood retention. Sufficient 
surface masking or administration of deferoxamine could be beneficial strategies in designing and 
clinical translation of future biomedical SPIONs.
Superparamagnetic iron oxide nanoparticles (SPIONs) have sparked commercial motivations in biomedical 
industry including cell labeling1, iron deficiency anemia2, targeted drug delivery3,4, magnetic resonance imag-
ing5 and immunotherapy6. Commercial SPIONs generally possess a physiosorbed dextran layer around their 
core. Unfortunately, these nanoparticles (NPs) have demonstrated toxicity and side effects in clinical trials7. For 
instance, 23% of patients receiving Ferumoxtran-10 (a dextran coated SPION) were reported to experience side 
effects8. Another main issue is that dextran undergoes biodegradation via various dextranases found in many 
tissues9. Unfortunately, replacing dextran with other polymeric coatings did not show promising results as well. 
For instance, commercial polyethylene glycol (PEG) modified SPIONs, such as Clariscan™ (NC100150), demon-
strated toxicity10.
Upon cell entry, biodegradation of SPIONs in endosomal environment generates oxidative stress which is 
known to be a major source of SPIONs toxicity11. It has been demonstrated that endosomal biodegradation of 
SPIONs leads to formation of ferric ions stored in ferritin12. These ions are then reduced to ferrous ions via reduc-
tases, leading to formation of oxidative stress13. It is also reported that dextran coated SPIONs are highly prone 
to biodegradation14. In addition to biodegradation, unprotected surface of SPIONs mediate the generation of 
hydroxyl radical through catalytic activity. Voinov et al. demonstrated that catalytic activity of the γ-Fe2O3 and 
Fe3O4 NPs is ascribed to the reactions at the NPs’ surface15. Furthermore, they reported that the catalytic centers 
on the NP surface were at least 50-fold more effective in the production of the OH• radical than the dissolved 
Fe2+ ions.
Even though it is believed that a masked surface of SPIONs could eliminate their adverse in vivo interactions11, 
few studies have focused on designing a polymeric corona to better mask the SPIONs surface. Moreover, one 
required aspect of bringing nanomedicine to patients is to fully realize the in vivo fate and biodistribution of 
NPs16.
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To better mask the surface of dextran coated SPIONs, we sought to formulate an additional coating around 
them. We hypothesized that a nanocomposite comprising of a second protective PEG layer around the dextran 
coated SPIONs may efficiently block the cytotoxic Fe ion leakage from the core or could limit the access of mole-
cules to the catalytic surface of SPIONs. Designed NPs is this study demonstrated that physisorption of sufficient 
amount of PEG layer around dextran coated SPIONs not only improves their colloidal stability, but also reduces 
the reactive oxygen species (ROS) generation compared with dextran coated SPIONs. We also assessed the influ-
ence of PEG/dextran double layer on biodistribution and pharmacokinetics of NPs, and results confirmed the 
proper surface coverage of SPIONs results in greater circulation time.
Results
In this study, SPIONs were coated with a double layer of dextran (interior layer) and PEG (exterior layer). In this 
respect, three samples were formulated i.e. (1) PDS0: a dextran coated SPIONs, (2) PDS1: a physically PEGylated 
PDS0 with 1:1 PEG:SPION weight ratio, and (3) PDS8: a physically PEGylated PDS0 with 8:1 PEG:SPION weight 
ratio. Following by detailed physicochemical evaluations, NPs were assessed for ROS generation in 3 cell lines 
through 4 h of co-incubation. Deferoxamine, an Fe chelator, was also employed as a control for Fe ion mediated 
ROS generation. Finally, biodistribution and pharmacokinetics of samples were evaluated within 24 h post injec-
tion of 2 mg/ml of samples.
Physicochemical characterization. 
•	 X-Ray Diffraction (XRD)
 Fig. S1 shows the XRD pattern of PDS0, PDS1, and PDS8. Magnetic particles in this study possess similar 
characteristic peaks of Fe3O4 as reported elsewhere17, and are well-matched with the magnetite (Fe3O4) 
diffraction peaks (JCPDS card no. 19-0629), confirming their inverse spinel structure. Greater PEG/SPIONs 
weight ratios culminate in depression of diffraction intensity, indicating higher amount of PEG on SPIONs.
•	 Raman Spectroscopy
To study the presence of the PEG/dextran double layer coating around SPIONs, we performed Raman spec-
troscopy for dried PDS0, PDS1, PDS8, as well as for pure dextran and PEG. Raman spectra of dextran18,19 
and PEG20 agree well with those reported in literature for the whole range of wavenumbers probed.
Raman spectrum of PDS0 below 800 cm−1 (Fig. 1a) is overwhelmed by the iron oxide bands21, however 
there are clearly dextran bands at higher wavenumbers. Most peak positions stayed the same with the 
exception of the C-O-H bending vibration of dextran18 at 916 cm−1, which shifts to 972 cm−1 (marked by 
black arrow on Fig. 1a). This indicates that almost all COH groups have reacted to produce dextran-SPION 
linkages.
 Fig. 1b shows Raman spectra of PEG and PDS8 and band assignments for various PEG molecular vibra-
tions, indicating the presence of PEG around dextran coated SPIONs (more descriptive information is 
provided in Supplementary Table 1). In the row of PDS0-PDS1-PDS8 (Fig. 1c), C-O-H bending vibration 
gradually disappears, as dextran constitutes an even smaller fraction of the complex particle. At the same 
time, PEG vibrations become more and more pronounced. Interestingly, the C-O stretch of PDS8 is less 
than 8 times higher (only about 2 times higher) than that of PDS1, indicating that bonding between PEG 
and dextran-coated SPIONS is most effective for PDS1, while PDS8 has longer sections of PEG without 
attachments. This is further confirmed by strong CH2 bands for PDS8 (860, 1238, 1284 and 1484 cm−1) that 
can be barely observed for PDS1. Apparently, these vibrations are heavily restricted in the PEG segments 
confined between SPIONs. These bands are even higher for pure PEG, where there are no such restrictions.
•	 Fourier transform infrared spectroscopy (FTIR)
To further investigate the physical bond formation between PEG and dextran, FTIR spectroscopy was 
Figure 1. Raman spectra of (a) dextran and PDS0, (b) PEG and PDS8, and (c) PDS0, PDS1 and PDS8, 
normalized to iron oxide bands. C-O-H bending vibration of dextran is marked with a black arrow. 
Characteristic bands for PEG and PDS8 in the fingerprint region have been identified and summarized in 
Supplementary Table 1.
www.nature.com/scientificreports/
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conducted. Fig. S2-a shows the characteristic bands of PEG, which the –C–O–C– ether stretch band and 
the vibration band (antisymmetric stretch) are appeared at 1101.1 cm−1 and 1349.4 cm−1, respectively22. In 
addition, the absorption bands at 1281.3 cm−1 and 1468.8 cm−1 attribute to the vibration of –CH223. Fig. S2-
b shows the FTIR bands for bare SPIONs to ease the comparison. In the broad peak near 3450 cm−1 belongs 
to attached hydroxyl groups22. PDS1 spectrum (Fig. S2-c) comprises the main absorbance of ether stretch 
band at 1098.9 cm−1 and –CH2 vibrational band at 1275 cm−1 and 1459 cm−1. Fig. S2-d shows PDS8 spec-
trum demonstrates the main absorbance of ether stretch band at 1097.8 cm−1 and –CH2 vibrational band 
at 1273 cm−1 and 1461 cm−1. These spectra verify the presence of PEG on the surface of NPs. However, the 
characteristic absorbance peaks of PEG show a slight shift to lower frequencies (red shift) due to changing 
the environment of PEG22 as well as hydrogen bonding between PEG and dextran24.
Another important point is that the wavenumber of δO–H deformation modes of dextran hydroxyl group25 
for PDS0, PDS1, and PDS8 are 1620 cm−1, 1634.8 cm−1, and 1634.8 cm−1, respectively, which suggests 
dextran-PEG interaction in PDS1 and PDS8 samples. Besides, –CH2 transmittance band for samples PDS0, 
and PDS1 are 2920 cm−1, 2912 cm−1, and 2908 cm−1, respectively. This redshift is likely due to lengthening of 
C–H bond24 caused by more interaction between PEG and dextran. These results in their totality are likely 
to reveal that hydrogen bonds have been formed between the PEG and dextran in PEGylated samples.
•	 Thermogravimetric analysis (TGA)
Weight loss curves are presented in Fig. S3. The first stage of weight loss that onsets from early stage up to 
180 °C is due to the evaporation of water molecules. The second stage starting from 220 °C to 400 °C is at-
tributed to the dextran and PEG degradation26. The incline in weight loss is the proof of increase in coating 
density around the surface of SPIONs. The weight loss boosts from 15% in PDS1 to 71% for PDS8, demon-
strating the higher amount of immobilized PEG around PDS8.
•	 Vibrating sample magnetometer (VSM)
Magnetic properties were obtained via VSM at 300 K. Fig. S4 shows magnetic response, and the lack of 
hysteresis loop indicates the superparamagnetic nature of all the samples. Ms values slightly decreased by 
addition of coating and the corresponding Ms values are provided in Supplementary Table 2. To correctly 
compare saturation magnetization (Ms) values, the Ms values were normalized to the mass of iron oxide27. 
It is generally believed that the Ms reduction of coated NPs is due to surface protection of the coating 
agents28,29. Further, it is established that the polymeric corona (shell) interacts with the surface atoms of 
the magnetic particles (core), leading to formation of a magnetically disordered layer, which reduces the 
magnetic phase17.
•	 Atomic Force Microscopy
To study the size, morphology, and the polymeric coating around SPIONs, we conducted AFM analysis. 
Fig. 2 demonstrates height and phase images associated with each sample. PDS0 shows nanoscale particles, 
but at the same time large (micron-scale) aggregates are also observable (Fig. 2 and Fig. S5). Following by 
adding PEG, we could not observe these aggregates, but smaller-scale clusters appeared following by PEGyl-
ation in sample PDS8. Sample PDS1, however, showed both large aggregates and smaller clusters. To further 
validate these observations, electron microscopy was conducted.
•	 Electron Microscopy analysis
Similar to the AFM observations, both scanning and transmission electron microscopy analyses demonstrated 
that individual NPs as well as large aggregates are present in PDS0 (Fig. S6). By addition of PEG, large aggregates 
were not observable, however, small colonies were formed (sample PDS8). From the physicochemical charac-
terization of NPs in this study we proposed a model in Fig. 3, which demonstrates the schematic representation 
of possible polymeric corona and the bonding between components. It should be noted that PDS0 are mostly 
separate but also with some clumps formed by capillary forces acting on the drying sample. When dynamic light 
scattering (DLS) results are combined with AFM and electron microscopy data (Supplementary Table 3), it is 
apparent that hydrodynamic size increases with PEGylation ratio, suggesting that large artifacts in PDS0 sample 
are drying artifacts.
Colloidal Stability Assessment of NPs. We measured the optical absorbance of NPs which is a function 
of sedimentation of agglomerated particles caused by gravitational forces30. As shown in Fig. 4a, the relative 
absorbance of samples PDS0 to PDS8 in DI-H2O is reported over a period of a month at room temperature. 
Results indicate that PDS8 possesses greatest colloidal stability over the experiment period, as the relative absorb-
ance decreased by 9% after 30 days, whereas for PDS0 the relative absorbance reduced by 9% in the third day of 
experiment and decreased by 75% after 30 days. It should be noted that no sensible change in UV absorption was 
observed for the PDS8 sample up to 17 days after initial date of experiment. Noteworthy to mention that samples 
maintained their colloidal stability at 4 °C for 6 months.
Early settling down of PDS0 sample was observed as A/A0 decreases within the second day of experiment. 
However, the physical appearance was the same during the first ten days, with no visible sedimentation. The sedi-
mentation rate decreases as the PEG/SPION weight ratio reaches its critical concentration in PDS8 sample. While 
for the PDS1 sample the first detectable decrease in absorbance occurs as early as the second day of experiment, 
settling down was not observed for the PDS8 sample up to 20 about days. One reason that the exterior PEG layer 
enhances the colloidal stability is due to its flexible nature. PEG has highly flexible hydrocarbon chains, with many 
plausible conformations. This behavior leads to formation of a conformational “cloud” around the NPs31.
DLS study was performed to further analyze the hydrodynamic size variations over time (Fig. 4b). At day 0, 
PDS0 had the least hydrodynamic size (32.4 ± 8.1 nm). The hydrodynamic size profiles of PDS1 and PDS8 match 
(46.2 ± 4.9 and 53.0 ± 7.5), although after 10 days they start to deviate.
www.nature.com/scientificreports/
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The growth rate of hydrodynamic diameter over time could be considered as colloidal stability measurement. 
For instance, size of PDS0 demonstrates the fastest growth rate over other samples, while PDS8 manifests the 
lowest rate of hydrodynamic size growth. These results indicate that incorporation of a second PEG layer around 
the initial dextran layer enhances the colloidal stability of particles, even though the bonding between the layers 
are purely physical. Another point is that the amount of PEG layer dictates the hydrodynamic size, and colloidal 
behavior of samples.
To mimic the in vivo colloidal behavior of NPs, relative UV absorbance of NPs was measured in cell culture 
medium (CCM). Fig. 4c illustrates the relative absorbance of samples in RPMI 1640 medium + 10% FBS. At early 
stage of colloidal stability, UV absorption behavior of PDS0 manifested a long-range elevation (hook effect) in 
absorption (Fig. 4c), which may be explained by the prevalence of dimer formation30. This elevation that initi-
ates following by 1.5 h incorporation of PDS0 in CCM, indicates SPIONs coated with dextran tend to coagulate 
rapidly. As the PEG layer added, coagulation kinetic changes significantly. For instance, the sudden coagulation 
onset of 1.5 h for PDS0 shifts to about 4 h and 5 h for PDS1 and PDS8, respectively (Fig. 4c). This observation is 
consistent with a previous study, where EDC/NHS chemistry was employed to conjugate PEG to SPIONs10.
The long initial increase in relative absorbance for PDS0 and PDS1 eventually decreases, which originates from 
gravitational settling of aggregates. PDS8, in contrast to PDS0 and PDS1, shows a constant relative absorption up 
to 5 h. The difference between the colloidal stability of PDS1 and PDS8 suggests that there exists a threshold for 
Figure 2. Analysis of NPs with one square micron AFM maps of SPION nanoparticles. Figures in the left and 
right represent the height and phase images, respectively. The dextran coated particles (PDS0) are forming large 
aggregates as well as individual NPs, and PEGylation leads to less large-scale aggregation, and smaller-scale 
clusters. The topography maps for PDS1 and PDS8 show the formation of complex aggregates of NPs where 
individual particles are connected by PEG.
www.nature.com/scientificreports/
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sufficient surface coverage. Such observation is in agreement with a previous report32. Indeed, a high PEG packing 
density has been found to be crucial to prevent adsorption of especially small proteins27, which is mainly due to 
the formation of conformation cloud that we discussed earlier.
Coating Influence on ROS generation. We sought to elucidate the effect of different coatings developed 
in this study on the Fe ion leaching, using Anodic Spike Voltammetry (ASV) responses of NPs. The stripping peak 
at −0.84 and +0.75 volt in Fig. 5a shows the concentration of free Fe3+ and Fe2+, respectively33, which is likely to 
originate from the leaching of Fe ions from the surface of SPIONs into the medium. By increasing the PEG weight 
ratio, the concentration of free Fe ions decreases to the point where the ASV cannot sense free Fe ions for PDS8.
To further investigate the effect of PEG on controlling the generation of intracellular ROS, DCFH-DA 
fluorescent dye was employed. Following by cardiomyocyte, cardiac progenitor cells (CPC), and RAW 264.7 
macrophages exposure to three concentrations of NPs (0.1, 0.5, and 1 mM) for 4 h, DCF fluorescence level was 
measured as the relative ratio of negative control (untreated cells). Figs 5b,c and d demonstrate the generation of 
hydroxyl using the fluorescent dye DCFH-DA in cardiomyocytes, CPCs, and RAW 264.7 macrophages, respec-
tively. We then picked the phagocytotic cell line (RAW 264.7 macrophages) and performed cell uptake analysis 
(Fig. S7). Moreover, a control group was also tested for ROS generation by adding deferoxamine, a well-known 
iron chelator (Fig. S8). Addition of 100 µM deferoxamine reduced the ROS generation in cells exposed to PDS0 
and PDS1 throughout all tested concentrations. Albeit, ROS generation mediated by PDS8 was not influenced by 
the presence of deferoxamine, probably due to comparable ROS generations of cells exposed to PDS8 with nega-
tive control. These results in their totality suggest that an optimized PEGylation could reduce the ROS generation 
likely due to less NPs biodegradation and/or reduced surface availability of NPs for catalytic activity.
Biodistribution and pharmacokinetics. To evaluate the clinical relevancy, we performed the qualitative 
analysis to find out the fate of NPs in a mouse model. Histological analysis of tissue sections stained with Prussian 
blue are shown in Fig. 6a. Results ascertained that the fate of NPs 24 h post injection is mainly marginal zones 
around the white pulp region of the spleen, which is in agreement with previous reports34. Figs 6b,c shows quan-
tified results for spleen and liver of mice (n = 3).
To assess whether physisorbed PEG influences stealth properties of NPs, in vivo pharmacokinetic study was 
conducted. Mice were intravenously (i.v.) injected with 100 μL of 2 mg/mL NPs (core weight). Blood was with-
drawn at 5 different time points within 24 h post injection, and Fe concentration was measured via ICP-OES. 
100 μL of PBS was injected to mice as control to measure the intrinsic iron content of the blood, owing to the pres-
ence of elemental iron in the hemoglobin of blood. Fig. 6d indicates that PEG incorporation creates enhancement 
of blood retention over other samples. As we expected, PDS0 demonstrated the least circulation half-life, where 
they rapidly cleared out of blood circulation, and could not be detected after 8 h of injection.
Discussion
Despite their recognized biomedical benefits, safety concerns have impaired the clinical translation of SPIONs. 
Unprotected surface of SPIONs mediate the generation of hydroxyl radical through catalytic activity15. In addi-
tion, biodegradation of SPIONs in endosomal environment generates oxidative stress known to be the major 
source of SPIONs toxicity11. Commercial classes of SPIONs are generally coated with dextran, and some reports 
have shown that this formulation is highly prone to biodegradation14. In the present study, we hypothesized that 
a double layer polymeric corona rather than a single layer could limit the release of Fe ions from SPIONs and/or 
limits the accessibility of molecules to the catalytic surface of SPIONs at the core. Therefore, SPIONs were first 
coated with a dextran layer following by immobilization of different amount of exterior PEG layer. Extensive 
physicochemical analyses confirmed the presence of both layers around SPIONs.
Figure 3. Schematic representation of corona formation around NPs, and the suggested physical bonding 
between PEG and dextran (dash lines between the PEG and dextran represent Hydrogen bonding).
www.nature.com/scientificreports/
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Colloidal stability assessments showed rapid coagulation of dextran coated SPIONs due to the weak phy-
sisorption of the dextran to the SPIONs27. Other reports also have indicated that dextran coatings on iron oxide 
NPs are prone to detachment, coagulation, and precipitation35. We observed that addition of PEG layer declined 
the coagulation kinetic. For instance, the sudden onset of coagulation for PDS1 shifts to about 4 h comparing to 
1.5 h for PDS0 (Fig. 4c). This offers that the presence of the outermost PEG layer protects NPs from fast agglom-
eration, likely due to reduction of biomolecules access to the core of NPs. Moreover, PEG reduces undesired 
interaction with plasma proteins, resulting in superior colloidal stability36.
Other noticeable fact in colloidal stability study is that increase in absorbance appeared in CCM, but not the 
aqueous medium. This elevation occurs because of two opposing effects: (i) the reduction in UV absorption due 
to particle sedimentation, and (ii) increase in UV absorption arising from particles aggregation. Particles exposed 
to CCM experience a rapid agglomeration kinetic that even the decrease in UV absorption cannot compensate 
the absorption enhancement30.
Figure 4. Colloidal Stability assessment of NPs in DI H2O and cell culture media. (a) The absorbance of the 
NPs was measured at different time points and normalized over initial absorbance. Relative absorbance of 
samples, and (b) particle hydrodynamic size stability over time are measured in DI H2O (n = 3) to evaluate the 
colloidal stability. (c) Relative absorbance of samples was also assessed in RPMI 1640 + 10% FBS to simulate 
their colloidal stability in physiological media. Samples for colloidal stability experiment in cell culture were 
kept in incubator during the time of experiment. Error bars indicate mean ± SD (n = 3).
www.nature.com/scientificreports/
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As we hypothesized in this work, a proper coating around the surface of NPs could minimize the release of Fe 
ions. Our electrochemical analysis (Fig. 5a) revealed that certain ratio of PEG/dextran around SPIONs (PDS8) 
may efficiently prevent the leaching of Fe2+ and Fe3+ ions. To further validate the protective effect of PDS8 formu-
lation on masking the core of NPs, we tested the mediating effects of NPs on cells ROS generation. Noteworthy 
that both ions could generate ROS37–39. Fe3+ can turn into Fe2+, and Fe2+ can react with hydrogen peroxide 
and the oxygen produced by the mitochondria to generate highly reactive hydroxyl ions (•OH) via Fenton or 
Haber-Weiss reactions11,35. •OH then creates toxicity by attacking single or double strands in DNA, and reacting 
with lipid and polysaccharides.
Due to their different behavior towards ROS, cardiomyocytes and CPCs were chosen to study NPs ROS gen-
eration. While cardiomyocytes have peroxidase-like activity40,41 that limits their sensitivity to ROS, CPCs are 
susceptible to elevated levels of ROS42,43. In addition, a phagocytotic cell line (RAW 264.7 macrophage) was also 
assessed. Below 1 mM NPs concentration, PDS8 formulation considerably reduced ROS generation for CPCs and 
RAW 264.7 compared to PDS0 (Fig. 5c,d). For cardiomyocytes, however, PDS8 did not induce a notable change in 
ROS level for NPs concentration higher than 0.1 mM. This is likely due to the fact that SPIONs could even reduce 
the intracellular ROS concentration of cardiomyocytes through peroxidase-like activity of cardiomyocytes40. The 
reason behind insignificant ROS generation at higher NPs concentration is not clear to us. Albeit, a recent work 
also reported a significant ROS production at intermediate concentrations of SPIONs, but not higher concentra-
tions44. In their work, the maximum ROS concentration was observed at 10 and 50 µg/ml of SPIONs, but not at 
higher concentrations (i.e. 150, 200, and 250 µg/ml). The concentrations of our samples are 0.1, 0.5, and 1 mM, 
which corresponds to 20, 100, and 200 µg/ml, respectively. Therefore, we postulate that the less ROS production 
at SPIONs concentration of 1 mM (200 µg/ml) is probably owing to the antioxidant effects of cells44.
We also found that the amount of PEGylation influences the ROS production, where the lower amount of 
PEG (PDS1) at 0.1 mM SPIONs surprisingly shows negative impact and enhances the ROS production. This 
could be due to larger diameters of PDS1, putting them in a suitable range for maximum cell uptake45 (Fig. S7, 
Supplementary Table 3). At >0.1 mM concentrations the cell uptake of PEGylated NPs was higher but not sig-
nificant, which agrees with previous reports that there is a plateau for cellular uptake of NPs as a function of con-
centration46. In addition, mild PEGylation is probably not sufficient to control Fe2+ and Fe3+ ion release (Fig. 5a). 
Thus, the combination of higher uptake and incomplete surface protection are two possible reasons that PDS1 
demonstrates higher ROS generation at low concentrations.
To further asses the correlation between Fe ion release and ROS generation, we hypothesized that chelating Fe 
ions with an iron chelator in the cell culture may reduce the ROS production of our NPs. We found that 100 µM 
deferoxamine remarkably reduces the ROS production in PDS0 and PDS1 samples (Fig. S8) after 4 h on NPs 
Figure 5. Effect of coating on Reactive Oxygen Species (ROS) generation. Anodic Spike Voltammetry analysis 
of NPs (a) shows that addition of PEG weight ratio around NPs reduces the release of Fe2+ and Fe3+. Generation 
of hydroxyl ion using the fluorescent dye DCFH-DA in cardiomyocytes, cardiac progenitor cells and RAW 
264.7 macrophages cultured with NPs for 4 h are shown in (b), (c) and (d), respectively. It was revealed that 
incorporation of cells with PDS8 in either of the concentrations does not induce significant hydroxyl generation 
and is comparable with negative control. Statistical analysis was assessed against PDS0, where *, and ** denote 
p < 0.05, and p < 0.01, respectively. Data represent mean ± SD (n = 3).
www.nature.com/scientificreports/
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incubation with RAW 264.7 cells. Deferoxamine did not reduce the ROS generation in PDS8 samples, which is 
likely due to the sufficient blocking of Fe ion release by PDS8 formulation comparable to negative control.
Here we studied the influence of surface masking on ROS generation over a short-term basis (4 h incubation). 
Longer surface masking of SPIONs could be achieved with inert inorganic moieties such as gold47 and silica48. For 
instance, it has been shown that a protective gold layer plays a shielding effect and prevents the massive intracel-
lular biodegradation of SPIONs over one month47.
We observed that PDS0 tended to accumulate in liver more than PDS1 and PDS8 24 h following i.v. injection 
(Fig. 6a,b). One possible explanation is that PEGylation reduces the phagocytosis of NPs by liver kupffer cells, 
providing more time for the macrophages of spleen to remove NPs from the blood49. Marginal zones around the 
white pulp region of the spleen were the major destination of injected NPs. Interestingly, we found a heterogenous 
sub-tissue distribution of PEGylated NPs in the spleen specially for PDS8 (Fig. 6c). We also could not observe any 
iron accumulation in brain, heart, and lung, which is consistent with observations reported elsewhere50. While 
these observations provide an initial proof of concept, quantitative analysis (e.g. ICP-MS) should be conducted in 
the future studies for accurate comparison of biodistributions. Finally, PDS8 showed enhanced blood retention 
time (15.28% ± 5.31, p = 0.048) compared to PDS0 (3.88% ± 1.78) 8 hours following administration (Fig. 6d). A 
recent study reported a half-life of 155 mins on covalently bonded PEG (5 kDa) on SPIONs51, while the half-life of 
PDS8 in our study is less than 1 h, which is likely due to the weak attachment of PEG to NPs.
Conclusion
In summary, we immobilized a PEG layer around dextran-coated SPIONs to fabricate a double layer protection 
around the core NPs. The presence and amount of external PEG layer enhanced colloidal stability, and influenced 
ROS generation, biodistribution and pharmacokinetic of NPs. Optimum amount of PEG layer reduced the ROS 
generation mediated by SPIONs, likely due to less biodegradation and/or reduced surface availability of NPs 
for catalytic activity. Addition of deferoxamine, an iron chelator, also reduced the ROS generation by SPIONs. 
Moreover, NPs concentration and cell type were two critical factors determining the ROS generation profile of 
NPs. While results from 24 h NPs injection indicated that PEG immobilization did not remarkably alter the blood 
Figure 6. Biodistribution and blood retention analyses 24 h post injection. (a) 40 μm tissue sections from 
different organs were stained by Prussian blue. Control group was injected with PBS. Dark blue spots indicate 
the presence of Fe. Note that natural ferric ions exist in spleen. Figures are taken by 10X magnification. Image 
quantification results for (b) liver and (c) spleen. (n = 3) (d) Blood retentions of samples over 24-h post 
injection. All the mice were administered intravenously with 2 mg/mL dose of NPs. Data represent mean ± SD 
(n = 3) of injected dose percentage against time. Statistical analysis was assessed against PDS0.
www.nature.com/scientificreports/
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retention, biodistribution in liver was reduced and NPs distribution in spleen demonstrated a more heterogenous 
profile. Our work suggests that sufficient surface masking or administration of deferoxamine could be beneficial 
in designing and clinical translation of future biomedical SPIONs.
Methods
Materials. All the chemical reagents were of analytical grade and used without further purification, unless 
otherwise noted. The detailed reagents were included in the supplementary materials.
Preparation of PEG/dextran coated iron oxide NPs. Dextran coated SPIONs (PDS0) were synthe-
sized via coprecipitation method as reported elsewhere52 with some modification. The detailed procedures were 
included in the supplementary materials. We employed a very facile technique to physically immobilize PEG 
around dextran coated SPIONs via adding PEG to other two batches with the following weight ratios of PEG/
SPION: 1/1, and 8/1 (samples PDS1, and PDS8, respectively) and stirred for 24 hours via magnetic stirrer at 
1000 rpm. Next, all samples were separated over a strong NdFeB magnet and the supernatant was decanted. 
Finally, obtained NPs underwent additional sonication step to breakdown any agglomerated clusters formed 
during magnetic decantation to be used as suspension for colloidal evaluations.
Characterization methods. Physicochemical properties of NPs were characterized using various methods, 
and the detailed procedures were included in the supplementary materials.
Colloidal stability studies. Colloidal stability analyses were conducted based on optical absorbance den-
sity of the prepared suspensions measured via a UV-VIS spectrophotometer (Agilent Cary 6000i UV/Vis/NIR, 
USA). Samples were diluted with DI H2O and their concentrations were adjusted to be 50 μM. Colloidal stability 
was assessed based relative absorption (A) over the initial absorbance value (A0). Experiments in CCM were per-
formed by pipetting 100 μL of 50 μM samples to 3.9 ml of the RPMI 1640 cell culture medium supplemented with 
10% FBS. Subsequently, absorption through 1 cm light pathway square glass cuvette was recorded (λ = 550 nm). 
Measurements were carried out in triplicate. The obtained optical densities were plotted as A/A0 against time.
Elechtrochemical analysis. Anodic Spike Voltammetry (ASV) was conducted using the microfabricated 
three electrode system connected to Interface 1000 potentiostat (Gamry Instruments). NPs concentration were 
adjusted to be 100 µM. The three electrode system consisted of microfabricated Pt working electrode, Pt counter 
electrode and a Ag/AgCl reference electrode. Using the known standard reduction potential of the reference elec-
trode, the potential applied to the working electrode by means of the potentiostat was controlled and regulated 
and the redox reactions were studied by measurement of the current. In this experiment, the Pt working electrode 
was held at a constant potential of -1.5 V for 120 s and then scanned towards 1.5 V vs. the Ag/AgCl reference 
electrode53. The other important parameters for this experiment includes a frequency of 25 Hz and a pulse size 
of 25 mV.
The iron oxide NPs are accumulated around the reference electrode when held at a constant potential while 
gaining electrons. Subsequently, when the potential is scanned towards 1.5 V, the iron oxide NPs return into the 
solution and the measured current corresponds to their concentration on the surface.
Determination of reactive oxygen species. RAW 264.7 macrophages, CPCs and cardiomyocytes were 
plated in a 96 well plate at a density of 10,000 cells per well. RAW 264.7 macrophages were cultured in DMEM 
medium with 10% FBS with 1% antibiotic. CPCs were cultured in DMEM/F12 medium with embryonic stem 
cell FBS and plated on a 0.2% gelatin-coated 96-well plate. Cardiomyocytes were cultured in RPMI with B27 
supplement and plated on a matrigel coated 96 well plate. The cells were cultured at 37 °C in a 5% CO2 incubator. 
Cardiomyocytes were less than 30 days of age post-differentiation. Cells were cultured in 100 μl medium for each 
well for 24 h, following by addition of the medium containing three different concentrations of SPIONs i.e. 0.1, 
0.5, and 1 mM (The amount of iron was confirmed via atomic absorption). The control wells contained CCM 
without SPIONs. Another negative control was tested by adding 100 μM of deferoxamine to SPIONs containing 
batches. Tests were conducted in triplicate, and all samples including the control, were placed in five wells to pro-
vide statistically reliable results. The intracellular amount of ROS is a critical biomarker for oxidative stress, and 
elevated level of ROS is generally an indication for increased oxidative stress. Generation of ROS was assessed 
via the fluorescent dye DCFH-DA, which is a nonpolar compound converted by cellular estrases to fluorescent 
2′,7′-Dichlorofluorescin (DCF). Intracellular ROS turns a non-fluorescent DCFH-DA to fluorescent DCF. After 
treatment of cells with NPs for 4 h, cells were washed with PBS and loaded with DCFH-DA (20 μM) and incu-
bated for 30 minutes at 37 °C, and 5% CO2 atmosphere. Hydrogen peroxide-treated cells (100 μM H2O2) and 
untreated cells were used as positive and negative controls, respectively. In addition, a control group was also 
tested by adding 100 µM of deferoxamine, a well-known iron chelator. Cells were then washed twice with PBS 
(to prevent interference) and analyzed using the FlexStation 3 multiplate reader at an excitation wavelength of 
485 nm and emission wavelength of 535 nm. Data are expressed as fluorescence ratio compared with the relevant 
negative controls.
Cell uptake, in vivo pharmacokinetics, and biodistribution studies. The detailed procedures were 
included in the supplementary materials. Seven-week old CD-1 female mice were used in this study. Animal 
handling, surveillance, and experimentation were performed by Bayside BioSciences Inc. in accordance with and 
approval from the Stanford University Administrative Panel on Laboratory Animal Care (protocol no. 2016-021).
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Statistical analysis. Statistical differences were analyzed by two-tailed t-test using Microsoft Excel software 
with analysis tool pack add-ins (Microsoft Inc., USA). Probabilities were marked as p < 0.05 (*), p < 0.01 (**), 
and n.s. denotes as non-significant in each figure.
Data availability. All data generated or analysed during this study are included in this published article and 
its Supplementary Information files and available from the corresponding author on reasonable request.
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